GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Change In Inventory : ₹0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2000. Start your Free Trial

What is GlaxoSmithKline Pharmaceuticals Change In Inventory?

GlaxoSmithKline Pharmaceuticals's change in inventory for the quarter that ended in Mar. 2025 was ₹0 Mil. It means GlaxoSmithKline Pharmaceuticals's inventory stayed the same from Dec. 2024 to Mar. 2025 .

GlaxoSmithKline Pharmaceuticals's change in inventory for the fiscal year that ended in Mar. 2025 was ₹433 Mil. It means GlaxoSmithKline Pharmaceuticals's inventory declined by ₹433 Mil from Mar. 2024 to Mar. 2025 .

GlaxoSmithKline Pharmaceuticals's Total Inventories for the quarter that ended in Mar. 2025 was ₹4,817 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. GlaxoSmithKline Pharmaceuticals's Days Inventory for the quarter that ended in Mar. 2025 was 62.45.

Inventory Turnover measures how fast the company turns over its inventory within a year. GlaxoSmithKline Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2025 was 1.46.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. GlaxoSmithKline Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.25.

GlaxoSmithKline Pharmaceuticals Change In Inventory Historical Data

The historical data trend for GlaxoSmithKline Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Pharmaceuticals Change In Inventory Chart

GlaxoSmithKline Pharmaceuticals Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Change In Inventory

Get a 7-Day Free Trial

-467.93

120.03

747.25

-650.80

433.10

GlaxoSmithKline Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

GlaxoSmithKline Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

GlaxoSmithKline Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	2408.7	/	3519.4	*	365 / 4
	=	62.45

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

GlaxoSmithKline Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	3519.4	/	2408.7
	=	1.46

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

GlaxoSmithKline Pharmaceuticals's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	2408.7	/	9743.7
	=	0.25

GlaxoSmithKline Pharmaceuticals Change In Inventory Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Pharmaceuticals's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Pharmaceuticals Ltd (NSE:GLAXO) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

500660:India

Address

Dr. Annie Besant Road, GSK House, Worli, Mumbai, MH, IND, 400030

Website

https://www.gsk-india.com

GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives majority of its revenue from India.

GlaxoSmithKline Pharmaceuticals Headlines

No Headlines